The clinical trials below are Dermavant Science, Inc. sponsored and are retrieved from the U.S. National Library of Medicine: ClinicalTrials.gov

Study Title Phase Condition Intervention Status Location
Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo Phase 2 Vitiligo Cerdulatinib 0.37% gel Completed Dermavant Investigational Site, Irvine, California, United States
Dermavant Investigational Site, Worcester, Massachusetts, United States
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102) Phase 3 Atopic Dermatitis tapinarof cream, 1% Recruiting Dermavant Clinical Site, Birmingham, Alabama, United States
Dermavant Clinical Site, Scottsdale, Arizona, United StatesDermavant Clinical Site, Scottsdale, Arizona, United StatesDermavant Clinical Site, Fort Smith, Arkansas, United StatesDermavant Clinical Site, Cerritos, California, United StatesDermavant Clinical Site, Huntington Beach, California, United StatesDermavant Clinical Site, Lancaster, California, United StatesDermavant Clinical Site, Los Angeles, California, United StatesDermavant Clinical Site, Santa Ana, California, United StatesDermavant Clinical Site, Santa Monica, California, United StatesDermavant Clinical Site, Boca Raton, Florida, United StatesDermavant Clinical Site, Delray Beach, Florida, United StatesDermavant Clinical Site, Jacksonville, Florida, United StatesDermavant Clinical Site, Miami, Florida, United StatesDermavant Clinical Site, Tampa, Florida, United StatesDermavant Clinical Site, Snellville, Georgia, United StatesDermavant Clinical Site, Evansville, Indiana, United StatesDermavant Clinical Site, Overland Park, Kansas, United StatesDermavant Clinical Site, Lexington, Kentucky, United StatesDermavant Clinical Site, Baton Rouge, Louisiana, United StatesDermavant Clinical Site, Baton Rouge, Louisiana, United StatesDermavant Clinical Site, New Orleans, Louisiana, United StatesDermavant Clinical Site, Rockville, Maryland, United StatesDermavant Clinical Site, Omaha, Nebraska, United StatesDermavant Clinical Site, Las Vegas, Nevada, United StatesDermavant Clinical Site, Watertown, New York, United StatesDermavant Clinical Site, Charlotte, North Carolina, United StatesDermavant Clinical Site, Dayton, Ohio, United StatesDermavant Clinical Site, Mayfield Heights, Ohio, United StatesDermavant Clinical Site, Tulsa, Oklahoma, United StatesDermavant Clinical Site, Medford, Oregon, United StatesDermavant Clinical Site, Portland, Oregon, United StatesDermavant Clinical Site, Warwick, Rhode Island, United StatesDermavant Clinical Site, Anderson, South Carolina, United StatesDermavant Clinical Site, Spartanburg, South Carolina, United StatesDermavant Clinical Site, Memphis, Tennessee, United StatesDermavant Clinical Site, Bellaire, Texas, United StatesDermavant Clinical Site, Dripping Springs, Texas, United StatesDermavant Clinical Site, Houston, Texas, United StatesDermavant Clinical Site, Houston, Texas, United StatesDermavant Clinical Site, San Antonio, Texas, United StatesDermavant Clinical Site, Webster, Texas, United StatesDermavant Clinical Site, Spokane, Washington, United StatesDermavant Clinical Site, Surrey, British Columbia, CanadaDermavant Clinical Site, Barrie, Ontario, CanadaDermavant Clinical Site, Markham, Ontario, CanadaDermavant Clinical Site, Waterloo, Ontario, CanadaDermavant Clinical Site, Windsor, Ontario, Canada
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults Phase 3 Atopic Dermatitis tapinarof cream, 1% Recruiting Dermavant Clinical Site, Birmingham, Alabama, United States
Dermavant Clinical Site, Phoenix, Arizona, United StatesDermavant Clinical Site, Bryant, Arkansas, United StatesDermavant Clinical Site, Fountain Valley, California, United StatesDermavant Clinical Site, Fremont, California, United StatesDermavant Clinical Site, Inglewood, California, United StatesDermavant Clinical Site, Los Angeles, California, United StatesDermavant Clinical Site, Mission Viejo, California, United StatesDermavant Clinical Site, Boca Raton, Florida, United StatesDermavant Clinical Site, Boca Raton, Florida, United StatesDermavant Clinical Site, Jacksonville, Florida, United StatesDermavant Clinical Site, Margate, Florida, United StatesDermavant Clinical Site, Miami Lakes, Florida, United StatesDermavant Clinical Site, Orlando, Florida, United StatesDermavant Clinical Site, Pinellas Park, Florida, United StatesDermavant Clinical Site, Sandy Springs, Georgia, United StatesDermavant Clinical Site, Savannah, Georgia, United StatesDermavant Clinical Site, Plainfield, Indiana, United StatesDermavant Clinical Site, Louisville, Kentucky, United StatesDermavant Clinical Site, Covington, Louisiana, United StatesDermavant Clinical Site, Monroe, Louisiana, United StatesDermavant Clinical Site, Largo, Maryland, United StatesDermavant Clinical Site, Bay City, Michigan, United StatesDermavant Clinical Site, Clarkston, Michigan, United StatesDermavant Clinical Site, Warren, Michigan, United StatesDermavant Clinical Site, Ypsilanti, Michigan, United StatesDermavant Clinical Site, New Brighton, Minnesota, United StatesDermavant Clinical Site, Missoula, Montana, United StatesDermavant Clinical Site, Omaha, Nebraska, United StatesDermavant Clinical Site, Garden City, New York, United StatesDermavant Clinical Site, Bexley, Ohio, United StatesDermavant Clinical Site, Oklahoma City, Oklahoma, United StatesDermavant Clinical Site, Oklahoma City, Oklahoma, United StatesDermavant Clinical Site, Gresham, Oregon, United StatesDermavant Clinical Site, Portland, Oregon, United StatesDermavant Clinical Site, Greenville, South Carolina, United StatesDermavant Clinical Site, Knoxville, Tennessee, United StatesDermavant Clinical Site, Austin, Texas, United StatesDermavant Clinical Site, Cypress, Texas, United StatesDermavant Clinical Site, Dallas, Texas, United StatesDermavant Clinical Site, Houston, Texas, United StatesDermavant Clinical Site, San Antonio, Texas, United StatesDermavant Clinical Site, San Antonio, Texas, United StatesDermavant Clinical Site, Sugar Land, Texas, United StatesDermavant Clinical Site, Richmond, Virginia, United StatesDermavant Clinical Site, Winnipeg, Manitoba, CanadaDermavant Clinical Site, Burlington, Ontario, CanadaDermavant Clinical Site, Cobourg, Ontario, CanadaDermavant Clinical Site, Hamilton, Ontario, CanadaDermavant Clinical Site, Oakville, Ontario, CanadaDermavant Clinical Site, Ottawa, Ontario, CanadaDermavant Clinical Site, Montréal, Quebec, Canada
Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis Phase 2 Plaque Psoriasis Tapinarof cream, 1% Completed Dermavant Investigational Site, Encino, California, United States
Dermavant Investigational Site, Sanford, Florida, United StatesDermavant Investigational Site, Philadelphia, Pennsylvania, United StatesDermavant Investigational Site, Austin, Texas, United StatesDermavant Investigational Site, San Antonio, Texas, United StatesDermavant Investigational Site, Spokane, Washington, United States
Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis Phase 3 Atopic Dermatitis Tapinarof cream, 1% Recruiting Dermavant Clinical Site, Birmingham, Alabama, United States
Dermavant Clinical Site, Phoenix, Arizona, United StatesDermavant Clinical Site, Scottsdale, Arizona, United StatesDermavant Clinical Site, Scottsdale, Arizona, United StatesDermavant Clinical Site, Bryant, Arkansas, United StatesDermavant Clinical Site, Fort Smith, Arkansas, United StatesDermavant Clinical Site, Cerritos, California, United StatesDermavant Clinical Site, Fountain Valley, California, United StatesDermavant Clinical Site, Fremont, California, United StatesDermavant Clinical Site, Huntington Beach, California, United StatesDermavant Clinical Site, Inglewood, California, United StatesDermavant Clinical Site, Lancaster, California, United StatesDermavant Clinical Site, Los Angeles, California, United StatesDermavant Clinical Site, Los Angeles, California, United StatesDermavant Clinical Site, Mission Viejo, California, United StatesDermavant Clinical Site, Santa Ana, California, United StatesDermavant Clinical Site, Santa Monica, California, United StatesDermavant Clinical Site, Thousand Oaks, California, United StatesDermavant Clinical Site, Boca Raton, Florida, United StatesDermavant Clinical Site, Boca Raton, Florida, United StatesDermavant Clinical Site, Coral Gables, Florida, United StatesDermavant Clinical Site, Delray Beach, Florida, United StatesDermavant Clinical Site, Hialeah, Florida, United StatesDermavant Clinical Site, Jacksonville, Florida, United StatesDermavant Clinical Site, Margate, Florida, United StatesDermavant Clinical Site, Miami Lakes, Florida, United StatesDermavant Clinical Site, Miami, Florida, United StatesDermavant Clinical Site, Orlando, Florida, United StatesDermavant Clinical Site, Pinellas Park, Florida, United StatesDermavant Clinical Site, Tampa, Florida, United StatesDermavant Clinical Site, Sandy Springs, Georgia, United StatesDermavant Clinical Site, Savannah, Georgia, United StatesDermavant Clinical Site, Evansville, Indiana, United StatesDermavant Clinical Site, Plainfield, Indiana, United StatesDermavant Clinical Site, Lexington, Kentucky, United StatesDermavant Clinical Site, Louisville, Kentucky, United StatesDermavant Clinical Site, Baton Rouge, Louisiana, United StatesDermavant Clinical Site, Covington, Louisiana, United StatesDermavant Clinical Site, Monroe, Louisiana, United StatesDermavant Clinical Site, New Orleans, Louisiana, United StatesDermavant Clinical Site, Largo, Maryland, United StatesDermavant Clinical Site, Rockville, Maryland, United StatesDermavant Clinical Site, Bay City, Michigan, United StatesDermavant Clinical Site, Clarkston, Michigan, United StatesDermavant Clinical Site, Warren, Michigan, United StatesDermavant Clinical Site, Ypsilanti, Michigan, United StatesDermavant Clinical Site, New Brighton, Minnesota, United StatesDermavant Clinical Site, Missoula, Montana, United StatesDermavant Clinical Site, Omaha, Nebraska, United StatesDermavant Clinical Site, Garden City, New York, United StatesDermavant Clinical Site, Bexley, Ohio, United StatesDermavant Clinical Site, Dayton, Ohio, United StatesDermavant Clinical Site, Mayfield Heights, Ohio, United StatesDermavant Clinical Site, Norman, Oklahoma, United StatesDermavant Clinical Site, Oklahoma City, Oklahoma, United StatesDermavant Clinical Site, Tulsa, Oklahoma, United StatesDermavant Clinical Site, Portland, Oregon, United StatesDermavant Clinical Site, Portland, Oregon, United StatesDermavant Clinical Site, Anderson, South Carolina, United StatesDermavant Clinical Site, Greenville, South Carolina, United StatesDermavant Clinical Site, Mount Pleasant, South Carolina, United StatesDermavant Clinical Site, Spartanburg, South Carolina, United StatesDermavant Clinical Site, Knoxville, Tennessee, United StatesDermavant Clinical Site, Memphis, Tennessee, United StatesDermavant Clinical Site, Cypress, Texas, United StatesDermavant Clinical Site, Dripping Springs, Texas, United StatesDermavant Clinical Site, San Antonio, Texas, United StatesDermavant Clinical Site, San Antonio, Texas, United StatesDermavant Clinical Site, San Antonio, Texas, United StatesDermavant Clinical Site, Sugar Land, Texas, United StatesDermavant Clinical Site, Spokane, Washington, United StatesDermavant Clinical Site, Surrey, British Columbia, CanadaDermavant Clinical Site, Barrie, Ontario, CanadaDermavant Clinical Site, Oakville, Ontario, CanadaDermavant Clinical Site, Ottawa, Ontario, CanadaDermavant Clinical Site, Waterloo, Ontario, CanadaDermavant Clinical Site, Windsor, Ontario, Canada
Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects Phase 3 Plaque Psoriasis tapinarof cream, 1% Recruiting Dermavant Clinical Site, Rogers, Arkansas, United States
Dermavant Clinical Site, Miami Lakes, Florida, United StatesDermavant Clinical Site, Indianapolis, Indiana, United StatesDermavant Clinical Site, West Lafayette, Indiana, United StatesDermavant Clinical Site, Fairborn, Ohio, United StatesDermavant Clinical Site, Portland, Oregon, United StatesDermavant Clinical Site, Spokane, Washington, United StatesDermavant Clinical Site, Markham, Ontario, CanadaDermavant Clinical Trials, Oshawa, Ontario, CanadaDermavant Clinical Site, Waterloo, Ontario, CanadaDermavant Clinical Site, Montréal, Quebec, Canada
Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003) Phase 3 Plaque Psoriasis tapinarof cream, 1% Completed Dermavant Investigative Site, Birmingham, Alabama, United States
Dermavant Investigative Site, Phoenix, Arizona, United StatesDermavant Investigative Site, Bryant, Arkansas, United StatesDermavant Investigative Site, Fort Smith, Arkansas, United StatesDermavant Investigative Site, Fountain Valley, California, United StatesDermavant Investigative Site, Fremont, California, United StatesDermavant Investigative Site, Fresno, California, United StatesDermavant Investigative Site, Los Angeles, California, United StatesDermavant Investigative Site, Los Angeles, California, United StatesDermavant Investigative Site, Northridge, California, United StatesDermavant Investigative Site, Oceanside, California, United StatesDermavant Investigative Site, San Diego, California, United StatesDermavant Investigative Site, Santa Ana, California, United StatesDermavant Investigative Site, Santa Monica, California, United StatesDermavant Investigative Site, Denver, Colorado, United StatesDermavant Investigative Site, Cromwell, Connecticut, United StatesDermavant Investigative Site, Boca Raton, Florida, United StatesDermavant Investigative Site, Boynton Beach, Florida, United StatesDermavant Investigative Site, Hialeah, Florida, United StatesDermavant Investigative Site, Margate, Florida, United StatesDermavant Investigative Site, Miami, Florida, United StatesDermavant Investigative Site, Miramar, Florida, United StatesDermavant Investigative Site, Boise, Idaho, United StatesDermavant Investigative Site, Rolling Meadows, Illinois, United StatesDermavant Investigative Site, Evansville, Indiana, United StatesDermavant Investigative Site, Indianapolis, Indiana, United StatesDermavant Investigative Site, New Albany, Indiana, United StatesDermavant Investigative Site, Plainfield, Indiana, United StatesDermavant Investigative Site, Overland Park, Kansas, United StatesDermavant Investigative Site, Louisville, Kentucky, United StatesDermavant Investigative Site, Owensboro, Kentucky, United StatesDermavant Investigative Site, Baton Rouge, Louisiana, United StatesDermavant Investigative Site, New Orleans, Louisiana, United StatesDermavant Investigative Site, Rockville, Maryland, United StatesDermavant Investigative Site, Boston, Massachusetts, United StatesDermavant Investigative Site, Bay City, Michigan, United StatesDermavant Investigative Site, Clarkston, Michigan, United StatesDermavant Clinical Site, Detroit, Michigan, United StatesDermavant Investigational Site, Detroit, Michigan, United StatesDermavant Investigative Site, Fort Gratiot, Michigan, United StatesDermavant Investigative Site, Warren, Michigan, United StatesDermavant Investigative Site, Fridley, Minnesota, United StatesDermavant Investigative Site, Saint Joseph, Missouri, United StatesDermavant Investigative Site, Omaha, Nebraska, United StatesDermavant Clinical Site, Las Vegas, Nevada, United StatesDermavant Investigative Site, Las Vegas, Nevada, United StatesDermavant Investigative Site, East Windsor, New Jersey, United StatesDermavant Investigative Site, Hackensack, New Jersey, United StatesDermavant Investigative Site, Verona, New Jersey, United StatesDermavant Clinical Site, Brooklyn, New York, United StatesDermavant Investigative Site, Kew Gardens, New York, United StatesDermavant Investigative Site, New York, New York, United StatesDermavant Investigative Site, Rochester, New York, United StatesDermavant Investigative Site, Stony Brook, New York, United StatesDermavant Clinical Site, Watertown, New York, United StatesDermavant Investigative Site, Cary, North Carolina, United StatesDermavant Investigative Site, High Point, North Carolina, United StatesDermavant Investigative Site, Wilmington, North Carolina, United StatesDermavant Investigative Site, Winston-Salem, North Carolina, United StatesDermavant Investigative Site, Beachwood, Ohio, United StatesDermavant Investigative Site, Bexley, Ohio, United StatesDermavant Investigative Site, Norman, Oklahoma, United StatesDermavant Investigate Site, Norman, Oklahoma, United StatesDermavant Investigative Site, Norman, Oklahoma, United StatesDermavant Clinical Site, Gresham, Oregon, United StatesDermavant Investigative Site, Portland, Oregon, United StatesDermavant Investigative Site, Portland, Oregon, United StatesDermavant Investigative Site, Pittsburgh, Pennsylvania, United StatesDermavant Investigative Site, Johnston, Rhode Island, United StatesDermavant Investigative Site, Charleston, South Carolina, United StatesDermavant Investigative Site, Nashville, Tennessee, United StatesDermavant Investigative Site, Arlington, Texas, United StatesDermavant Clinical Site, Bellaire, Texas, United StatesDermavant Investigative Site, College Station, Texas, United StatesDermavant Investigative Site, Dripping Springs, Texas, United StatesDermavant Investigative Site, Houston, Texas, United StatesDermavant Clinical Site, Houston, Texas, United StatesDermavant Investigative Site, Pflugerville, Texas, United StatesDermavant Investigative Site, Plano, Texas, United StatesDermavant Investigative Site, San Antonio, Texas, United StatesDermavant Investigative Site, San Antonio, Texas, United StatesDermavant Investigative Site, Webster, Texas, United StatesDermavant Investigative Site, West Jordan, Utah, United StatesDermavant Investigative Site, Norfolk, Virginia, United StatesDermavant Investigative Site, Spokane, Washington, United StatesDermavant Investigative Site, Edmonton, Alberta, CanadaDermavant Investigative Site, Surrey, Bristish Columbia, CanadaDermavant Investigative Site, Surrey, British Columbia, CanadaDermavant Investigative Site, Ajax, Ontario, CanadaDermavant Clinical Site, Burlington, Ontario, CanadaDermavant Investigative Site, Cobourg, Ontario, CanadaDermavant Investigative Site, Etobicoke, Ontario, CanadaDermavant Investigative Site, Hamilton, Ontario, CanadaDermavant Clinical Site, Hamilton, Ontario, CanadaDermavant Investigative Site, Markham, Ontario, CanadaDermavant Clinical Site, Markham, Ontario, CanadaDermavant Investigative Site, North Bay, Ontario, CanadaDermavant Investigative Site, Oakville, Ontario, CanadaDermavant Investigative Site, Ottawa, Ontario, CanadaDermavant Investigative Site, Richmond Hill, Ontario, CanadaDermavant Investigative Site, Toronto, Ontario, CanadaDermavant Investigative Site, Waterloo, Ontario, CanadaDermavant Investigative Site, Windsor, Ontario, CanadaDermavant Investigative Site, Montréal, Quebec, Canada
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002) Phase 3 Plaque Psoriasis Tapinarof Completed Dermavant Investigative Site, Fort Smith, Arkansas, United States
Dermavant Investigative Site, Fountain Valley, California, United StatesDermavant Investigative Site, Fremont, California, United StatesDermavant Investigative Site, Los Angeles, California, United StatesDermavant Investigative Site, Oceanside, California, United StatesDermavant Investigative Site, San Diego, California, United StatesDermavant Investigative Site, Santa Monica, California, United StatesDermavant Investigative Site, Denver, Colorado, United StatesDermavant Investigative Site, Boynton Beach, Florida, United StatesDermavant Investigative Site, Margate, Florida, United StatesDermavant Investigative Site, Miami, Florida, United StatesDermavant Investigative Site, Boise, Idaho, United StatesDermavant Investigative Site, Rolling Meadows, Illinois, United StatesDermavant Investigative Site, Plainfield, Indiana, United StatesDermavant Investigative Site, Overland Park, Kansas, United StatesDermavant Investigative Site, Louisville, Kentucky, United StatesDermavant Investigative Site, Owensboro, Kentucky, United StatesDermavant Investigative Site, Metairie, Louisiana, United StatesDermavant Investigative Site, Boston, Massachusetts, United StatesDermavant Investigative Site, Bay City, Michigan, United StatesDermavant Investigative Site, Detroit, Michigan, United StatesDermavant Investigative Site, Fort Gratiot, Michigan, United StatesDermavant Investigative Site, Fridley, Minnesota, United StatesDermavant Investigative Site, Omaha, Nebraska, United StatesDermavant Investigative Site, Las Vegas, Nevada, United StatesDermavant Investigative Site, East Windsor, New Jersey, United StatesDermavant Investigative Site, Hackensack, New Jersey, United StatesDermavant Investigative Site, Stony Brook, New York, United StatesDermavant Investigative Site, Wilmington, North Carolina, United StatesDermavant Investigative Site, Winston-Salem, North Carolina, United StatesDermavant Investigative Site, Beachwood, Ohio, United StatesDermavant Investigative Site, Bexley, Ohio, United StatesDermavant Investigative Site, Portland, Oregon, United StatesDermavant Investigative Site, Charleston, South Carolina, United StatesDermavant Investigative Site, Nashville, Tennessee, United StatesDermavant Investigative Site, Houston, Texas, United StatesDermavant Investigative Site, Pflugerville, Texas, United StatesDermavant Investigative Site, Plano, Texas, United StatesDermavant Investigative Site, San Antonio, Texas, United StatesDermavant Investigative Site, Webster, Texas, United StatesDermavant Investigative Site, Norfolk, Virginia, United StatesDermavant Investigative Site, Spokane, Washington, United StatesDermavant Investigative Site, Edmonton, Alberta, CanadaDermavant Investigative Site, Surrey, Bristish Columbia, CanadaDermavant Investigative Site, Surrey, Bristish Columbia, CanadaDermavant Investigative Site, Etobicoke, Ontario, CanadaDermavant Investigative Site, Hamilton, Ontario, CanadaDermavant Investigative Site, Markham, Ontario, CanadaDermavant Investigative Site, Oakville, Ontario, CanadaDermavant Investigative Site, Ottawa, Ontario, Canada
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001) Phase 3 Plaque Psoriasis Tapinarof Completed Dermavant Investigative Site, Birmingham, Alabama, United States
Dermavant Investigative Site, Phoenix, Arizona, United StatesDermavant Investigative Site, Hot Springs, Arkansas, United StatesDermavant Investigative Site, Rogers, Arkansas, United StatesDermavant Investigative Site, Anaheim Hills, California, United StatesDermavant Investigative Site, Fresno, California, United StatesDermavant Investigative Site, Los Angeles, California, United StatesDermavant Investigative Site, Northridge, California, United StatesDermavant Investigative Site, San Diego, California, United StatesDermavant Investigative Site, Santa Ana, California, United StatesDermavant Investigative Site, Cromwell, Connecticut, United StatesDermavant Investigative Site, Boca Raton, Florida, United StatesDermavant Investigative Site, Brandon, Florida, United StatesDermavant Investigative Site, Hialeah, Florida, United StatesDermavant Investigative Site, Miramar, Florida, United StatesDermavant Investigative Site, Marietta, Georgia, United StatesDermavant Investigative Site, Evansville, Indiana, United StatesDermavant Investigative Site, Indianapolis, Indiana, United StatesDermavant Investigative Site, New Albany, Indiana, United StatesDermavant Investigative Site, Louisville, Kentucky, United StatesDermavant Investigative Site, Owensboro, Kentucky, United StatesDermavant Investigative Site, Baton Rouge, Louisiana, United StatesDermavant Investigative Site, New Orleans, Louisiana, United StatesDermavant Investigative Site, New Orleans, Louisiana, United StatesDermavant Investigative Site, Boston, Massachusetts, United StatesDermavant Investigative Site, Clarkston, Michigan, United StatesDermavant Investigative Site, Warren, Michigan, United StatesDermavant Investigative Site, Saint Joseph, Missouri, United StatesDermavant Investigative Site, Verona, New Jersey, United StatesDermavant Investigative Site, Kew Gardens, New York, United StatesDermavant Investigative Site, New York, New York, United StatesDermavant Investigative Site, Rochester, New York, United StatesDermavant Investigative Site, Cary, North Carolina, United StatesDermavant Investigative Site, High Point, North Carolina, United StatesDermavant Investigative Site, Norman, Oklahoma, United StatesDermavant Investigative Site, Portland, Oregon, United StatesDermavant Investigative Site, Pittsburgh, Pennsylvania, United StatesDermavant Investigative Site, Johnston, Rhode Island, United StatesDermavant Investigative Site, Arlington, Texas, United StatesDermavant Investigative Site, College Station, Texas, United StatesDermavant Investigative Site, Dripping Springs, Texas, United StatesDermavant Investigative Site, Houston, Texas, United StatesDermavant Investigative Site, San Antonio, Texas, United StatesDermavant Investigative Site, West Jordan, Utah, United StatesDermavant Investigative Site, Saint Johns, Newfoundland and Labrador, CanadaDermavant Investigative Site, Ajax, Ontario, CanadaDermavant Investigative Site, Coburg, Ontario, CanadaDermavant Investigative Site, North Bay, Ontario, CanadaDermavant Investigative Site, Richmond Hill, Ontario, CanadaDermavant Investigative Site, Toronto, Ontario, CanadaDermavant Investigative Site, Waterloo, Ontario, CanadaDermavant Investigative Site, Windsor, Ontario, CanadaDermavant Investigative Site, Montréal, Quebec, Canada
Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis Phase 1 Atopic Dermatitis RVT-501 0.5% topical ointment Unknown status Dermavant Investigational Site, Anniston, Alabama, United States
Dermavant Investigational Site, Irvine, California, United StatesDermavant Investigational Site, Jacksonville, Florida, United StatesDermavant Investigational Site, Miami, Florida, United StatesDermavant Investigational Site, Miami, Florida, United StatesDermavant Investigational Site, Stockbridge, Georgia, United StatesDermavant Investigational Site, Indianapolis, Indiana, United StatesDermavant Investigational Site, Raleigh, North Carolina, United StatesDermavant Investigational Site, Arlington, Texas, United StatesDermavant Investigational Site, San Antonio, Texas, United StatesDermavant Investigational Site, San Antonio, Texas, United StatesDermavant Investigational Site, Richmond, Virginia, United States
434,977 studies searched for dermavant. 16 matches were found and 10 studies were returned.